-
CDK9 inhibitor (A3294): Protocol Guide
2026-08-28
CDK9 inhibitor (A3294) is a selective serine/threonine kinase inhibitor for controlled studies of CDK9-dependent transcription elongation and HIV-1 propagation in MT4 cells. It is appropriate for target-selective biochemical and cellular workflows, but not for broad CDK inhibition, therapeutic inference, or long-term storage of prepared solutions.
-
Saquinavir Workflows for HIV Protease Research
2026-08-28
Build more reproducible Saquinavir experiments by combining HIV protease inhibition assays with biomimetic membrane profiling. This workflow distinguishes enzyme potency from membrane partitioning and provides practical troubleshooting for antiretroviral drug research and exploratory cancer research.
-
Ridaforolimus Workflows for mTOR Cancer Research
2026-08-27
Ridaforolimus (Deforolimus) combines nanomolar mTOR pathway control with practical applications in proliferation, signaling, VEGF, and senescence-oriented assays. This workflow-led guide shows how to select doses, validate pathway engagement, distinguish cytostasis from cell death, and troubleshoot variable responses across cancer models.
-
Sodium Salicylate in Stromal Signaling Research
2026-08-27
Sodium salicylate is more than an NF-κB inhibitor: it can serve as a mechanistic probe for connecting inflammatory signaling with stromal and oxidative-stress phenotypes. This article translates recent pancreatic tumor nanomedicine findings into more rigorous assay-design decisions without overstating the evidence.
-
Fluorouracil (Adrucil): Assay Best Practices
2026-08-26
This evidence-linked, scenario-driven guide explains how Fluorouracil (Adrucil), SKU A4071, can support interpretable cell viability, proliferation, and cytotoxicity experiments. It covers mechanism, concentration design, preparation, data interpretation, and practical product-selection criteria for colon and breast cancer research.
-
Gut T3SSs in Crohn’s Disease: Pathogenicity and Biomarkers
2026-08-26
This eBioMedicine study identifies functional type III secretion systems (T3SSs) in mesenteric-adipose-tissue-derived Achromobacter pulmonis and links them to aggravated colitis, epithelial and macrophage cytotoxicity, and Crohn’s disease-associated microbial signatures. Its combination of bacterial genomics, mouse modeling, cell coculture, and metagenomic biomarker validation provides a framework for connecting microbial virulence mechanisms with disease monitoring.
-
Mifepristone (RU486) Research Guide
2026-08-25
Mifepristone, also called RU486, is a progesterone receptor antagonist used to study reproductive signaling and preclinical tumor biology. The B1511 material supports concentration-controlled cell assays, while reported effects on ovarian cancer cell growth, uterine fibroid size, meningioma proliferation, and sperm function remain model- and context-dependent.
-
Cy5 amine (non-sulfonated): Practical Labeling Guide
2026-08-25
Cy5 amine (non-sulfonated) is a primary-amine cyanine reagent for covalent labeling through suitable activated esters, activated carboxy groups, or epoxides. It solves the need for a bright far-red label in microscopy, flow cytometry, and molecular tracking workflows, but its water insolubility requires preparation in DMSO or ethanol before transfer into an aqueous reaction.
-
Fluconazole for Biofilm Resistance Research
2026-08-24
Build more interpretable antifungal assays with Fluconazole, from solvent-controlled susceptibility testing to Candida albicans biofilm and infection-model studies. The workflow connects target-level inhibition with PP2A–autophagy biology, helping distinguish intrinsic resistance from biofilm-state effects.
-
2,7-Dichlorodihydrofluorescein diacetate for ROS
2026-08-24
2,7-Dichlorodihydrofluorescein diacetate, also known as DCFH-DA, provides a practical readout of intracellular oxidant activity. This guide connects probe chemistry with the CD44–copper–ROS mechanism reported in ulcerative colitis macrophages and explains how to design more interpretable assays.
-
Propidium Iodide in Host–Pathogen Cell Death
2026-08-23
Propidium iodide is more than a fluorescent viability marker: it can help resolve membrane failure during intracellular infection. This article connects PI assay design with the GRA12 virulence findings in Toxoplasma gondii while clarifying what the signal can—and cannot—prove.
-
SC 79: An Akt Probe for Lipotoxicity
2026-08-22
SC 79 is a cytosolic Akt activator that can help researchers separate protective Akt signaling from the mTORC1–IRE1α mechanisms of palmitate lipotoxicity. This article translates pathway evidence into rigorous assay design, controls, handling decisions, and cross-domain limitations.
-
2,5-di-tert-butylbenzene-1,4-diol (BHQ) Workflows
2026-08-21
Use BHQ as a practical SERCA perturbation tool for calcium signaling research, ER stress assays, vascular smooth muscle studies, and mechanistic hematopoietic stem cell workflows. This guide emphasizes solvent control, time-resolved calcium measurements, CXCR4-centered validation, and troubleshooting of redox and extracellular potassium confounders.
-
Necrostatin-1: RIP1 Kinase Inhibitor Workflows
2026-08-20
Build more discriminating necroptosis assays with Necrostatin-1, a selective RIP1 kinase inhibitor that connects cell-death signaling to inflammatory tissue injury. This guide translates evidence from cough variant asthma research into practical workflows, controls, and troubleshooting strategies for cell, lung, liver, and acute kidney injury models.
-
Remdesivir: Polymerase Biology for Better Assays
2026-08-20
Remdesivir (GS-5734) is examined through a polymerase-centered lens, connecting coronavirus and filovirus data with new structural insights into Nipah virus replication machinery. The article translates those findings into better assay design, interpretation, and compound-handling decisions.